|
Press Releases
All Releases
 |
Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
May 23, 2013
|
7.1 KB |
|
| |
CAMBRIDGE, Mass., May 23, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at two upcoming investor conferences.
38th Annual dbAccess Health Care Conference
Wednesd...
|
|
Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
May 9, 2013
|
7.1 KB |
|
| |
CAMBRIDGE, Mass., May 9, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at two upcoming investor conferences.
Bank of America Merrill Lynch 2013 Health Care Conference
...
|
|
Momenta Pharmaceuticals Reports First Quarter 2013 Financial Results
Apr 30, 2013
|
20.4 KB |
|
| |
CAMBRIDGE, Mass., April 30, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today reported its financial results for the quarter ended March 31, 2013.
For the first quarter of 2013, the company reported a net loss of $24.1 mi...
|
|
Momenta Pharmaceuticals Announces Date of First Quarter 2013 Financial Results Conference Call and Webcast
Apr 9, 2013
|
7.4 KB |
|
| |
CAMBRIDGE, Mass., April 9, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will release its financial results for the first quarter ended March 31, 2013 before the U.S. financial markets open on Tuesday, April 30, 2013.
Manag...
|
|
Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
Feb 25, 2013
|
7.3 KB |
|
| |
CAMBRIDGE, Mass., Feb. 25, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at two upcoming investor conferences.
Cowen and Company 33rd Annual Health C...
|
|
Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2012 Financial Results
Feb 15, 2013
|
22.9 KB |
|
| |
CAMBRIDGE, Mass., Feb. 15, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the fourth quarter and year ended December 31, 2012.
For the fourth quarter of 2012, the company reported a net loss of $(17.7) million, or $(0.35) per share compared to a net loss of $(1.3) million, or $(...
|
|
Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
Feb 7, 2013
|
7.1 KB |
|
| |
CAMBRIDGE, Mass., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at two upcoming investor conferences.
Leerink Swann Global Healthcare Conference 2013
Wednes...
|
|
Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2012 Financial Results Conference Call and Webcast
Jan 24, 2013
|
7.4 KB |
|
| |
CAMBRIDGE, Mass., Jan. 24, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will release its financial results for the fourth quarter ended December 31, 2012 before the U.S. financial markets open on Friday, February 15, 2013.
...
|
|
Momenta Pharmaceuticals to Present at the Deutsche Bank 2012 dbAccess BioFEST
Nov 27, 2012
|
6.9 KB |
|
| |
CAMBRIDGE, Mass., Nov. 27, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that its presentation at the Deutsche Bank 2012 dbAccess BioFEST will be webcast on Tuesday, December 4 at 1:05 p.m. ET.
The audio web...
|
|
U.S. Court of Appeals Denied Momenta Pharmaceuticals Petition for Rehearing En Banc in "Safe-Harbor" Case
Nov 20, 2012
|
10.7 KB |
|
| |
CAMBRIDGE, Mass., Nov. 20, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that the United States Court of Appeals for the Federal Circuit (CAFC) denied its request for a rehearing en banc to reconsider its three-judg...
|
|
Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
Nov 8, 2012
|
7.1 KB |
|
| |
CAMBRIDGE, Mass., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its corporate presentation at two upcoming investor conferences.
Lazard Capital Markets 9th Annual Healthcare Conf...
|
|
Momenta Pharmaceuticals Reports Third Quarter 2012 Financial Results
Nov 7, 2012
|
21.3 KB |
|
| |
CAMBRIDGE, Mass., Nov. 7, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today reported its financial results for the quarter ended September 30, 2012.
For the third quarter of 2012, the company reported a net loss of $25.8 ...
|
|
Momenta Pharmaceuticals Announces Date of Third Quarter 2012 Financial Results Conference Call
Oct 18, 2012
|
7.4 KB |
|
| |
CAMBRIDGE, Mass., Oct. 18, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will release its financial results for third quarter ended September 30, 2012 before the U.S. financial markets open on Wednesday, November 7, 2012.
M...
|
|
Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
Aug 30, 2012
|
7.1 KB |
|
| |
CAMBRIDGE, Mass., Aug. 30, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its corporate presentation at two upcoming investor conferences.
Stifel Nicolaus 2012 Healthcare Conference
...
|
|
Momenta to Present at the Canaccord Genuity 32nd Annual Growth Conference
Aug 8, 2012
|
6.9 KB |
|
| |
CAMBRIDGE, Mass., Aug. 8, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that its presentation at the Canaccord Genuity 32nd Annual Growth Conference will be webcast on Wednesday, August 15 at 9:00 a.m. ET.
T...
|
|
Momenta Pharmaceuticals Acknowledges Federal Circuit Opinion Supporting Order Issued January 26, 2012 in Ongoing Suit Against Amphastar Pharmaceuticals and Watson Pharmaceuticals
Aug 3, 2012
|
8.8 KB |
|
| |
CAMBRIDGE, Mass., Aug. 3, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that the United States Court of Appeals for the Federal Circuit issued its substantive opinion on its previous decision to stay the preliminary...
|
|
Momenta Pharmaceuticals Reports Second Quarter 2012 Financial Results
Aug 2, 2012
|
21.1 KB |
|
| |
CAMBRIDGE, Mass., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today reported its financial results for the quarter ended June 30, 2012.
For the second quarter of 2012, the company reported a net loss of $10.2 mill...
|
|
Momenta Pharmaceuticals Announces Date of Second Quarter 2012 Financial Results Conference Call
Jul 16, 2012
|
7.4 KB |
|
| |
CAMBRIDGE, Mass., July 16, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will release its financial results for second quarter ended June 30, 2012 before the U.S. financial markets open on Thursday, August 2, 2012.
Manageme...
|
|
First Patient Dosed With M402 in Phase 1/2 Clinical Trial in Metastatic Pancreatic Cancer
Jul 2, 2012
|
11.0 KB |
|
| |
CAMBRIDGE, Mass., July 2, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that dosing has begun in the Phase 1/2 proof-of-concept clinical trial of M402 in combination with gemcitabine in patients with advanced metast...
|
|
Momenta Pharmaceuticals Announces Decision in Teva Patent Litigation
Jun 22, 2012
|
8.1 KB |
|
| |
CAMBRIDGE, Mass., June 22, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that the District Court for the Southern District of New York has issued a decision in the patent litigation brought against Momenta by Teva i...
|
|
|
= add release to Briefcase
|
|
